Location History:
- Eagle Creek, OR (US) (2004)
- Portland, OR (US) (1988 - 2014)
- Gaithersburg, MD (US) (2018 - 2022)
Company Filing History:
5 out of 541 
4 out of 832,843 Years Active: 1988-2022
Title: The Innovative Contributions of Carl Hay
Introduction
Carl Hay is a prominent inventor based in Gaithersburg, MD (US), known for his significant contributions to the field of biotechnology. With a total of 9 patents to his name, he has made strides in developing therapeutic solutions for diseases associated with CD73 expression, particularly cancer.
Latest Patents
One of Carl Hay's latest patents is focused on binding molecules specific for CD73 and their uses. This patent provides anti-CD73 binding molecules, including antibodies and antigen-binding fragments. The disclosed compositions are designed for pharmaceutical formulations and methods aimed at diagnosing and treating diseases linked to CD73 expression, such as cancer. The therapeutic approaches include direct therapy with anti-CD73 binding molecules, adjuvant therapy with other anticancer agents, and combination therapies that integrate anti-CD73 molecules with chemotherapy.
Another notable patent involves therapeutic combinations featuring anti-CD73 antibodies, such as MEDI9447, and A2A receptor inhibitors. This invention outlines methods for utilizing these combinations to reduce tumor-mediated immunosuppression, showcasing the potential for innovative cancer treatments.
Career Highlights
Throughout his career, Carl Hay has worked with notable organizations, including Medimmune Limited. His work has significantly impacted the development of therapeutic strategies in oncology, particularly through his innovative patent contributions.
Collaborations
Carl has collaborated with talented individuals in his field, including Kris Sachsenmeier and Erin Sult. These partnerships have likely enhanced the development and application of his patented technologies.
Conclusion
Carl Hay's innovative work in biotechnology, particularly in the realm of cancer treatment, highlights his role as a leading inventor. His patents reflect a commitment to advancing medical science and improving patient outcomes.